Arena Pharmaceuticals: Investors Don't Know What to Think
News | 16 August 2012
Rumors in investing circles began spreading earlier this week that the firm that specializes in biotech could be the target of a takeover by a larger pharmaceutical firm. Whether or not this speculation will amount to anything in the long term remains ...
Click on the link to read the full article at Kapitall Blog (blog)
(This link will open in a new window)
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
